F15.21
Other stimulant dependence, in remission
Clinical Classification Guidelines
Inclusion Terms
- Amphetamine type substance use disorder, moderate, in early remission
- Amphetamine type substance use disorder, moderate, in sustained remission
- Amphetamine type substance use disorder, severe, in early remission
- Amphetamine type substance use disorder, severe, in sustained remission
- Other or unspecified stimulant use disorder, moderate, in early remission
- Other or unspecified stimulant use disorder, moderate, in sustained remission
- Other or unspecified stimulant use disorder, severe, in early remission
- Other or unspecified stimulant use disorder, severe, in sustained remission
Medical Intelligence & Overview
ICD-10 code F15.21 refers to cases where an individual has experienced dependence on stimulant substances, such as amphetamines, but is currently in remission. 'In remission' indicates that symptoms of dependence are not actively present, whether in early or sustained phases. This condition often affects individuals who have previously struggled with substance use disorders related to stimulants and are now maintaining a period of abstinence or controlled use under medical supervision.
Causes & Symptoms
Clinical Causes: Previous prolonged use of stimulant substances, particularly amphetamines Psychological dependence due to the rewarding effects of stimulants Environmental factors such as peer pressure or stressful environments that contributed to initial use Underlying mental health issues, including depression or anxiety, which may have prompted use Genetic predisposition toward addictive behaviors Lack of effective support systems during past use
Key Symptoms: Craving or strong desire to use stimulant substances Persistent thoughts about previous use or relapse Mood fluctuations, irritability, or anxiety during remission Physical symptoms such as fatigue or changes in appetite Possible sleep disturbances or insomnia Residual cognitive difficulties, like concentration challenges Avoidance of social situations associated with past stimulant use Concerns about maintaining abstinence or controlling use
Diagnostic & Treatment
Diagnosis Path: Diagnosis is based on clinical evaluation, which includes a thorough history of stimulant use, assessment of dependence severity, and confirmation of remission status. Healthcare providers often utilize structured interviews and diagnostic criteria to determine the presence and remission stage of stimulant use disorder. It’s crucial to evaluate for comorbid mental health conditions and assess the risk of relapse.
Treatment Protocols: Psychotherapy, such as cognitive-behavioral therapy (CBT), to develop coping skills and prevent relapse Support groups and peer counseling for ongoing motivation and accountability Monitoring and managing comorbid mental health conditions Education about triggers and avoiding high-risk situations Medical interventions if needed to address residual symptoms or mental health issues Relapse prevention strategies tailored to individual needs
Clinical Advice & FAQs
Billing Guidance
Is F15.21 a billable ICD-10 code?
Yes, F15.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.21?
Clinical documentation must specify the nature of Other stimulant dependence, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference